Market Trends of Medical Gloves Industry
Chemotherapy Segment is Expected to Record Significant Growth Over the Forecast Period
Medical gloves are used significantly in chemotherapy to minimize the potential mutagenic, carcinogenic, and teratogenic effects and occupational exposure to chemotherapy drugs. Personnel protective devices, particularly medical gloves, are crucial for preventing skin contact. Selecting the right gloves is paramount. To ensure optimal protection in oncology settings, comprehensive guidelines should be established, encompassing the evaluation of appropriate materials and the definition of quality standards.
Moreover, the demand for chemotherapy is expected to increase in the future as well due to the rising incidence of cancer. According to the American Cancer Society, in 2024, 2.0 million new cancer cases have been diagnosed, up from 1.93 million in 2023. Such a high incidence of cancer cases in the United States is expected to propel market growth due to the increased adoption of chemotherapy.
Furthermore, the rising strategies of market players are expected to drive the segment’s growth. For instance, in October 2022, ASAP Innovations launched its X-TRA Thick Black glove at the A + A Exhibition in Dusseldorf, Germany. The glove has been approved for use throughout the European Union and in the United Kingdom and offers the highest protection against exposure to many commonly used chemotherapy drugs. Such launches and exhibitions of gloves used in chemotherapy are expected to increase their adoption due to rising awareness, driving the segment’s growth.
With the increasing demand for chemotherapy, the demand for chemotherapy-grade gloves is also expected to increase. This is also expected to boost market growth.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same During the Forecast Period
The North American market holds significant growth due to the improved healthcare infrastructure, the strong foothold of key market players, rising hospitals, and rising initiatives from the market players, among others.
As per the National Ambulatory Care Reporting System (NACRS) in Canada, in December 2022, almost 14.0 million unscheduled emergency department visits were reported in Canada. Such a large number of emergency visits in Canada is expected to drive growth in the region due to the increased adoption of medical gloves in emergency departments.
Rising initiatives from key market players are expected to drive market growth in the region. For instance, in November 2022, Vizient Inc. entered into an agreement with SafeSource Direct for the manufacture of chemo-rated nitrile gloves. The agreement was the action by Vizient to increase supply assurance of critical medical supplies. In March 2022, United Safety Technology announced that it planned to build a new medical-grade glove manufacturing facility at Tradepoint Atlantic in Sparrows Point. Such initiatives are anticipated to drive market growth over the forecast period.
Increasing hospital visits and rising initiatives from market players are expected to increase the demand for medical gloves, which is expected to boost market growth in the region.
